中文名稱:Boceprevir-d9 | 英文名稱:Boceprevir-d9 |
CAS:1256751-11-7 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 1256751-11-7 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
Boceprevir-d9 | 500μg | 1256751-11-7 | EY-Y0163982 |
Cas No.1256751-11-7
別名 N/A
化學名 N/A
分子式 C27H36D9N5O5
分子量 528.7
溶解度 DMSO: Soluble,Methanol: Soluble
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Boceprevir-d9 is intended for use as an internal standard for the quantification of boceprevir by GC- or LC-MS. Boceprevir is an inhibitor of hepatitis C virus (HCV) non-structural protease 3/4A (NS3/4A; Ki = 14 nM for the HCV genotype 1b enzyme).1 Boceprevir inhibits HCV replication in Huh7 cells (EC50 = 200 nM).2 It also inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro; Ki = 1.8 μM) and reduces cytopathic effects of SARS-CoV-2 in Vero cells (EC50 = 1.31 μM).3 Formulations containing boceprevir have been used in the treatment of HCV.
1.Malcolm, B.A., Liu, R., Lahser, F., et al.SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cellsAntimicrob. Agents Chemother.50(3)1013-1020(2006) 2.Maren, T.H.Carbonic anhydrase: Chemistry, physiology, and inhibitionPhysiol. Rev.47(4)595-781(1967) 3.Ma, C., Sacco, M.D., Hurst, B., et al.Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main proteaseCell Res.30(8)678-692(2020)
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細胞培養(yǎng),分子生物學,免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥15 |
VIP4年
|
湖北科樂精細化工有限公司
|
2024-12-27 | |
詢價 |
VIP4年
|
武漢艾美捷科技有限公司
|
2024-12-20 | |
詢價 |
VIP11年
|
深圳振強生物技術(shù)有限公司
|
2024-12-27 |